Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM
Clinical trial NCT04466904 · COMPLETED
Trial details
- NCT number
- NCT04466904
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-12
- Primary completion
- 2021-05-28
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.